Professor Cruickshank’s research focus is arterial function and stiffness as a target for treating cardiovascular disease / diabetes, and specifically high blood pressure. His less clinical work is the origin of ethnic differences in these conditions over the life-course, particularly in Caribbean and West African origin peoples, and their inter-generational, non-genetic transmission. He has been a major investigator in many international clinical trials on high blood pressure and diabetes, including Ascot, Advance and currently the British Hypertension Society’s Pathway trials.